期刊文献+

自拟行肠汤干预慢传输型便秘的结肠动力学研究及疗效分析 被引量:6

Study on Colonic Motility and Efficacy Analysis in Patients with Slow-Transit Constipation Treated with Self-formulated Xingchang Decoction
下载PDF
导出
摘要 目的研究行肠汤加减干预对慢传输型便秘的结肠动力学的影响,观察其治疗慢传输型便秘的临床疗效。方法选择慢传输型便秘患者118例,分层区随机分为治疗组59例,予行肠汤加减治疗;对照组59例,予肠动力药莫沙必利治疗;疗程均为30天。观察两组治疗前后72 h结肠传输试验,疗程结束后观察两组症状积分,统计药物不良反应,并随访1年,比较复发率。结果治疗组临床症状积分显著改善,与对照组比较,差异有统计学意义(P<0.01);治疗组治愈率为76.27%,总有效率为93.22%,对照组治愈率为47.45%,总有效率为72.87%,两组比较,差异有统计学意义(P<0.01),治疗组1年复发率低于对照组(χ2=10.40,P=0.001);治疗组治疗后结肠传输功能改善优于对照组(P<0.01);两组治疗过程仅见轻度胃肠道反应,不良反应率低(治疗组5.08%;对照组8.47%),均未影响治疗。结论行肠汤能有效改善胃肠动力学,是治疗慢传输型便秘安全有效的药物。 Objective To observe the clinical efficacy of self-formulated Xingchang Decoction (XCD) in treating slow-transit constipation (S-I-C) and the dynamical parameters of colonic motility during XCD treatment. Methods One hundred and eighteen patients with STC were randomly assigned to the treatment group and the control group, 59 in each group. The treatment group was treated with XCD, and the control group was treated with mosapride, an intestinal energetic agent. The therapeutic course for both groups was 30 days. The 72-h colonic transition test was conducted and the symptom scores were observed before and after treatment; the adverse reaction rate and clinical efficacy were calculated after treatment; and the recurrence rate in one year was followed-up. Results Symptom scores were significantly improved in the treatment group after treatment, with the improvement significantly superior to that in the control group ( P 〈0.01 ). The cure rate and the total effective rate were 76.27% and 93.22% in the treatment group respectively, while they were 47.45% and 72.87% in the control group, showing significant difference between the two groups ( P 〈0. 01 ). Besides, the 1-year recurrence rate was significantly lower (χ2 = 10.40, P =0. 001 ) and the improvement of colonic motor function was more in the treatment group than those in the control group (P〈0.01 ). Only low incidence (5.08% in the treatment group and 8.47% in the control group) of mild gastrointestinal reactions was shown, which caused no influence on the treatment. Conclusion XCD could effectively improve the motility of the digestive tract, and it is effective and safe for the treatment of STC.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2009年第5期403-406,共4页 Chinese Journal of Integrated Traditional and Western Medicine
关键词 慢传输型便秘 自拟行肠汤 结肠动力 slow-transit constipation self-formulated Xingchang Decoction colonic motility
  • 相关文献

参考文献21

  • 1中华医学会消化病学分会胃肠动力学组.我国慢性便秘的诊治指南(草案)[J].中华消化杂志,2002,22(11):684-687. 被引量:157
  • 2Madrid AM, Defilippi C. Disturbances of small intestinal motility in patients with chronic constipation [J]. Rev Med Chil,2006,134(2):181-186. 被引量:1
  • 3GliaA, Lindberg G. Antroduodenal manometry findings in patients with slow-transit constipation [ J ]. Scand Gastroenterol,1998, 33(1):55-62. 被引量:1
  • 4Altomare DF, Portincasa P, Rinaldi M, et al. Slowtransit constipation: solitary symptom of a systemic gastrointestinal disease[J]. Dis Colon Rectum, 1999,42(2) :231-240. 被引量:1
  • 5Mollen RM, Hopman WP, Kuijpers HH, et al. Abnormalities of upper gut motility in patients with slow-transit constipation [J]. Eur J Gastroenterol Hepatol, 1999,11 (7):701-708. 被引量:1
  • 6Peracchi M, Basilisco G, Tagliabue R, et al. Post-prandial gut peptide plasma levels in women with idiopathic slow-transit constipation [J]. Scand J Gastroenterol,1999,34 (1) :25-28. 被引量:1
  • 7Thompson WG, Longstreth GF, Drossman DA, et al.Functional bowel disorders and functional abdominal pain[J]. Gut,1999,45 (2): Ⅱ43-Ⅱ47. 被引量:1
  • 8徐萍,吕农华.全国便秘专题研讨会纪要[J].中华内科杂志,2004,43(1):67-68. 被引量:45
  • 9杨新庆,田波.全国便秘诊治新进展学术研讨会(99’潍坊)会议纪要[J].大肠肛门病外科杂志,1999,5(4):1-3. 被引量:54
  • 10国家中医药管理局.中华人民共和国中医药行业标准[s].南京:南京大学出版社,1994.132. 被引量:68

二级参考文献59

共引文献588

同被引文献67

引证文献6

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部